PolyPeptide Group AG

PPGN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PPGN.SW stands at 664.88M. In comparison, SDZ.SW has a market cap of 16.38B. Regarding current trading prices, PPGN.SW is priced at $20.15, while SDZ.SW trades at $38.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PPGN.SW currently has a P/E ratio of -36.64, whereas SDZ.SW's P/E ratio is -1901.50. In terms of profitability, PPGN.SW's ROE is -0.05%, compared to SDZ.SW's ROE of +0.01%. Regarding short-term risk, PPGN.SW is more volatile compared to SDZ.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PPGN.SW.

PPGN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PPGN.SW stands at 664.88M. In comparison, EVT.SW has a market cap of 4.78B. Regarding current trading prices, PPGN.SW is priced at $20.15, while EVT.SW trades at $26.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PPGN.SW currently has a P/E ratio of -36.64, whereas EVT.SW's P/E ratio is -25.92. In terms of profitability, PPGN.SW's ROE is -0.05%, compared to EVT.SW's ROE of -0.19%. Regarding short-term risk, PPGN.SW is more volatile compared to EVT.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PPGN.SW.

PPGN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PPGN.SW stands at 664.88M. In comparison, SFZN.SW has a market cap of 4.40B. Regarding current trading prices, PPGN.SW is priced at $20.15, while SFZN.SW trades at $97.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PPGN.SW currently has a P/E ratio of -36.64, whereas SFZN.SW's P/E ratio is 26.45. In terms of profitability, PPGN.SW's ROE is -0.05%, compared to SFZN.SW's ROE of +0.14%. Regarding short-term risk, PPGN.SW is more volatile compared to SFZN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PPGN.SW.

PPGN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PPGN.SW stands at 664.88M. In comparison, VIFN.SW comparison data is unavailable. Regarding current trading prices, PPGN.SW is priced at $20.15, while VIFN.SW trades at $166.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PPGN.SW currently has a P/E ratio of -36.64, whereas VIFN.SW's P/E ratio is N/A. In terms of profitability, PPGN.SW's ROE is -0.05%, compared to VIFN.SW's ROE of +0.08%. Regarding short-term risk, PPGN.SW is more volatile compared to VIFN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PPGN.SW.

PPGN.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PPGN.SW stands at 664.88M. In comparison, MER.SW comparison data is unavailable. Regarding current trading prices, PPGN.SW is priced at $20.15, while MER.SW trades at $102.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PPGN.SW currently has a P/E ratio of -36.64, whereas MER.SW's P/E ratio is 14.20. In terms of profitability, PPGN.SW's ROE is -0.05%, compared to MER.SW's ROE of +0.14%. Regarding short-term risk, PPGN.SW is more volatile compared to MER.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PPGN.SW.